Rightslink® by Copyright Clearance Center

Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study

Author:

Mohamed Hassanein,Rachid Malek,Inass Shaltout,Rakesh Kumar Sahay,Mehmet Akif Buyukbese,Khier Djaballah,Valerie Pilorget,Mathieu Coudert,Saud Al Sifri

Publication:

Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Publisher:

Elsevier

Date:

February 2023

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.